Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
European Journal of Pharmacology
|
August 6, 1997
Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo
M J O'Neill, C P Bath, C P Dell, et al.
Neuropharmacology
|
December 23, 1999
[3H]ATPA: a high affinity ligand for GluR5 kainate receptors
K Hoo, B Legutko, G Rizkalla, et al.
Neuropharmacology
|
September 1, 1995
In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid
D D Schoepp, D Lodge, D Bleakman, et al.
Journal of Medicinal Chemistry
|
September 13, 1996
Synthesis of a series of aryl kainic acid analogs and evaluation in cells stably expressing the kainate receptor humGluR6
B E Cantrell, D M Zimmerman, J A Monn, et al.
Neuropharmacology
|
July 1, 1995
Characteristics of a human N-type calcium channel expressed in HEK293 cells
D Bleakman, D Bowman, C P Bath, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1998
Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons
A Pinto, S Gillard, F Moss, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 2, 2000
4-Alkylidenyl glutamic acids, potent and selective GluR5 agonists
S R Baker, D Bleakman, J Ezquerra, et al.
Neuropharmacology
|
January 1, 1997
LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors
D D Schoepp, B G Johnson, R A Wright, et al.
Neuropharmacology
|
June 19, 2001
Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro
P Miu, K R Jarvie, V Radhakrishnan, et al.
Journal of Medicinal Chemistry
|
May 23, 2000
4-Alkyl- and 4-cinnamylglutamic acid analogues are potent GluR5 kainate receptor agonists
C Pedregal, I Collado, A Escribano, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
European Journal of Pharmacology
|
August 6, 1997
Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo
M J O'Neill, C P Bath, C P Dell, et al.
Neuropharmacology
|
December 23, 1999
[3H]ATPA: a high affinity ligand for GluR5 kainate receptors
K Hoo, B Legutko, G Rizkalla, et al.
Neuropharmacology
|
September 1, 1995
In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid
D D Schoepp, D Lodge, D Bleakman, et al.
Journal of Medicinal Chemistry
|
September 13, 1996
Synthesis of a series of aryl kainic acid analogs and evaluation in cells stably expressing the kainate receptor humGluR6
B E Cantrell, D M Zimmerman, J A Monn, et al.
Neuropharmacology
|
July 1, 1995
Characteristics of a human N-type calcium channel expressed in HEK293 cells
D Bleakman, D Bowman, C P Bath, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1998
Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons
A Pinto, S Gillard, F Moss, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 2, 2000
4-Alkylidenyl glutamic acids, potent and selective GluR5 agonists
S R Baker, D Bleakman, J Ezquerra, et al.
Neuropharmacology
|
January 1, 1997
LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors
D D Schoepp, B G Johnson, R A Wright, et al.
Neuropharmacology
|
June 19, 2001
Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro
P Miu, K R Jarvie, V Radhakrishnan, et al.
Journal of Medicinal Chemistry
|
May 23, 2000
4-Alkyl- and 4-cinnamylglutamic acid analogues are potent GluR5 kainate receptor agonists
C Pedregal, I Collado, A Escribano, et al.
Page
of 6